CoChat

Sex Differences in Corticotropin-Releasing Factor Receptor-1 Action Within the Dorsal Raphe Nucleus in Stress Responsivity

Open access
Howerton, Alexis R., Roland, Alison V., Fluharty, Jessica M., Marshall, Anikò, Chen, Alon, Daniels, Derek, Beck, Sheryl G., Bale, Tracy L. · 2014 · Biological Psychiatry
Cited by 80

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background Women are twice as likely as men to suffer from stress-related affective disorders. Corticotropin-releasing factor (CRF) is an important link between stress and mood, in part through its signaling in the serotonergic dorsal raphe (DR). Development of CRF receptor-1 (CRFr1) antagonists has been a focus of numerous clinical trials, but has not yet been proven efficacious. We hypothesized that sex differences in CRFr1 modulation of DR circuits may be key determinants in predicting therapeutic responses and affective disorder vulnerability. Methods Male and female mice received DR infusions of the CRFr1 antagonist, NBI 35695, or CRF, and were evaluated for stress responsivity. Sex differences in indices of neural activation (cFos) and co-localization of CRFr1 throughout the DR were examined. Whole-cell patch-clamp electrophysiology assessed sex differences in serotonin neuron membrane characteristics and responsivity to CRF. Results Males showed robust behavioral and HPA axis responses to DR infusion of NBI 35695 and CRF, whereas females were minimally responsive. Sex differences were also found for both CRF induced DR cFos and CRFr1 co-localization throughout the DR. Electrophysiologically, female serotonergic neurons showed blunted membrane excitability, and divergent IPSC responses to CRF application. Conclusions These studies demonstrate convincing sex differences in CRFr1 activity in the DR, where blunted female responses to NBI 35695 and CRF suggest unique stress modulation of the DR. These sex differences may underlie affective disorder vulnerability and differential sensitivity to pharmacologic treatments developed to target the CRF system, thereby contributing to a current lack of CRFr1 antagonist efficacy in clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2013.10.013

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 80

Metadata

Authors
Howerton, A. R., Roland, A. V., Fluharty, J. M., Marshall, A., Chen, A., Daniels, D., Beck, S. G., & Bale, T. L.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2014-06
Volume
75
Issue
11
Pages
873-883
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2013828994
Cited by
80
References
12
FWCI
2.70
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex Differences in Corticotropin-Releasing Factor Receptor-1 Action Within the Dorsal Raphe Nucleus in Stress Responsivity. https://app.cochat.ai/papers/10.1016/j.biopsych.2013.10.013
The paper
Howerton, A. R., Roland, A. V., Fluharty, J. M., Marshall, A., Chen, A., Daniels, D., Beck, S. G., & Bale, T. L. (2014). Sex Differences in Corticotropin-Releasing Factor Receptor-1 Action Within the Dorsal Raphe Nucleus in Stress Responsivity. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2013.10.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.